Tscan therapeutics to participate in the jefferies healthcare conference

Waltham, mass., june 01, 2023 (globe newswire) -- tscan therapeutics, inc. (nasdaq: tcrx), a clinical-stage biopharmaceutical company focused on the development of t cell receptor (tcr)-engineered t cell therapies (tcr-t) for the treatment of patients with cancer, today announced that the company will participate in a fireside chat at the jefferies healthcare conference being held at the marriott marquis in new york, ny on thursday, june 8, 2023 at 8:00 a.m. eastern time.
TCRX Ratings Summary
TCRX Quant Ranking